NanoMedSyn develops proprietary vectors for drug delivery and protein degraders. Our drug-engineering platform is using a membrane receptor for endocytosis and degradation of pathogenic proteins in lysosomes. Applications concern immunotherapies of cancers, inflammatory and autoimmunes diseases.